𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial

✍ Scribed by Pierre Tran; Phil Skolnick; Pal Czobor; N.Y. Huang; Mark Bradshaw; Anthony McKinney; Maurizio Fava


Book ID
113750942
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
297 KB
Volume
46
Category
Article
ISSN
0022-3956

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES